Protocol Details Tesamorelin is administered as a daily subcutaneous injection, typically in the abdominal area
The bulk of BPC-157 research has focused on tissue repair (tendon, muscle, ligament, bone), gastrointestinal protection (ulcer models, IBD models, gut-brain axis), wound healing acceleration, and neuroprotection
Pharmacology & Therapeutics, 2007, 113(3): 546-593
The "stable in stomach acid" claim is incomplete Some vendor pages cite animal research showing BPC-157 is unusually resistant to gastric degradation compared to other peptides
No physician oversight and no legal recourse if something goes wrong
Ascorbic acid in Lipo C rarely causes GI upset at 100250mg doses